Published in Genes Cancer on November 01, 2011
LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma. Oncotarget (2015) 0.79
The NF1 somatic mutational landscape in sporadic human cancers. Hum Genomics (2017) 0.75
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (1983) 19.76
Tumour stem cells and drug resistance. Nat Rev Cancer (2005) 15.21
Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer (2003) 15.17
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (1984) 9.64
RAS oncogenes: the first 30 years. Nat Rev Cancer (2003) 8.61
Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst (1984) 4.01
The ras gene family and human carcinogenesis. Mutat Res (1988) 3.20
Tools of the trade: use of dominant-inhibitory mutants of Ras-family GTPases. Nat Cell Biol (1999) 3.18
Malignancy in neurofibromatosis type 1. Oncologist (2000) 2.78
Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis. Cancer Cell (2009) 2.73
Ras in cancer and developmental diseases. Genes Cancer (2011) 2.68
Cancer stem cells in radiation resistance. Cancer Res (2007) 2.59
Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res (1989) 2.19
NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome. Cell (2010) 1.81
Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia (2005) 1.75
Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor. Genes Dev (2003) 1.64
Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci U S A (1991) 1.55
Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ (1995) 1.52
Neurofibromatosis type 1 gene mutations in neuroblastoma. Nat Genet (1993) 1.48
Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res (1987) 1.47
Ras isoform abundance and signalling in human cancer cell lines. Oncogene (2007) 1.30
Isoform-specific ras functions in development and cancer. Future Oncol (2009) 1.29
Control of stemness by fibroblast growth factor signaling in stem cells and cancer stem cells. Curr Stem Cell Res Ther (2009) 1.25
Characterization of human neuroblastoma cell lines established before and after therapy. J Natl Cancer Inst (1986) 1.22
Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition. Biochem J (2004) 1.08
Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers. Cancer Res (1991) 1.08
Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells. Oncol Res (1997) 1.06
Neurofibromatosis type 1 and associated malignancies. Curr Neurol Neurosci Rep (2009) 1.03
Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells. Oncogene (2006) 0.93
Regulation of the Ras-GTPase activating protein neurofibromin by C-tail phosphorylation: implications for protein kinase C/Ras/extracellular signal-regulated kinase 1/2 pathway signaling and neuronal differentiation. J Neurochem (2009) 0.88
Ras/MEK signaling suppresses Myc-dependent apoptosis in cells transformed by c-myc and activated ras. Oncogene (2000) 0.86
Contrasting levels of p21ras activation and expression of neurofibromin in peripheral primitive neuroectodermal tumour and neuroblastoma cells, and their response to retinoic acid. J Neurol Sci (1998) 0.77
Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia (2005) 1.75
Human neuroblastoma stem cells. Semin Cancer Biol (2006) 1.33
A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors. Cancer Lett (2003) 1.28
Nestin is a potential mediator of malignancy in human neuroblastoma cells. J Biol Chem (2004) 1.27
Two-channel gastric pacing with a novel implantable gastric pacemaker accelerates glucagon-induced delayed gastric emptying in dogs. Am J Surg (2008) 0.92
MicroRNAs define distinct human neuroblastoma cell phenotypes and regulate their differentiation and tumorigenicity. BMC Cancer (2014) 0.88
Glucocorticoids induce neuroendocrine cell differentiation and increase expression of N-myc in N-type human neuroblastoma cells. Oncol Res (2002) 0.82
Two-channel gastric pacing in patients with diabetic gastroparesis. Neurogastroenterol Motil (2011) 0.81
A corrected karyotype for the SH-SY5Y human neuroblastoma cell line. Cancer Genet Cytogenet (2002) 0.81
The conundrum posed by cellular heterogeneity in analysis of human neuroblastoma. J Natl Cancer Inst (2004) 0.79
Nicotine stimulates expression of the PNMT gene through a novel promoter sequence. J Mol Neurosci (2005) 0.77